xColorado BioScience Association (CBSA) will highlight the future of health innovation at the Rocky Mountain Life Sciences Investor and Partnering Conference in Vail, Colo. on September 13 and 14. The conference connects the region’s most promising life sciences companies with investors and strategic partners from across the country.
Returning for the first time since 2019, the conference will welcome more than 200 attendees, including 60 life sciences presenting companies. Other attendees at the event, held at the Grand Hyatt Vail, include investors and strategic partners, service providers, and industry thought leaders. The agenda includes pitches from 30 life sciences companies, inspiration from a leading advocate for leading-edge cancer treatments, insights on the life sciences investment landscape, and dedicated time for partnering and networking.
“The caliber of life sciences innovations from the Rocky Mountain West is attracting top investors and strategic partners from across the U.S.,” said Elyse Blazevich, President and CEO of Colorado BioScience Association. “With the record-breaking registrations, it will be a dynamic and productive conference for our presenting companies, investors, and strategic partners.”
Presenting companies include 30 medtech, biotechnology, pharmaceutical, and digital health innovators, seeking between $1.5 million and $100 million in funding.
Original source can be found here.
Alerts Sign-up